RNF2 and acute myeloid leukemia: The small molecule inhibitor RB-3 has been designed and synthesized as a chemical probe that is able to disrupt the association of RING1B-BMI1 with chromatin and thereby inhibit H2A ubiquitination in human acute myeloid leukemia (AML) cells (24).